David Seaburg Is Bullish On AbbVie

David Seaburg spoke on CNBC's Fast Money about AbbVie Inc ABBV.

He said the company has an interesting cancer pipeline, which could provide a boost for the stock. He added that AbbVie has a 4 percent dividend yield and it trades at a discount at 14 times earnings.

Seaburg explained that there is going to be a news release in March about its oncology pipeline and he thinks that it could provide a positive boost to the stock. With positive news about the pipeline AbbVie could trade to $80, believes Seaburg.